CD4 and rheumatoid arthritis: Using this set of genes that have a very high probability of being relevant in the CD4+ T cell pathophysiology in RA, we finally performed the trans-eQTL analysis (NM9 = 3,435,556 tests, NM12 = 5,725,245 tests).